prostate header graphic
Prostate Problem Guide

The Use Of Medicine In BPH Treatment

There are a number of ways of treating BPH (benign prostatic hyperplasia or an enlarged prostate) of which medical treatments, or the use of drugs, is the commonest form of treatment following watchful waiting.

(Watchful waiting applies in cases where symptoms are mild or where the patient is not particularly troubled by his symptoms and involves simply checking on the patient once or twice a year to ensure that he is not developing complications as a result of his BPH. This can be a useful option for some patients as it avoids the risks associated with other forms of BPH treatment and, on occasions, the symptoms will actually lessen over time.)

One commonly used group of drugs in BPH treatment are alpha-blockers which were originally designed for the treatment of high blood pressure. Alpha-blockers act to relax the muscles of the prostate gland, as well as the neck of the bladder, and so reduce pressure on the urethra and improve the flow of urine.

Although alpha-blockers relieve BPH symptoms they do not reduce the size of the prostate and so the symptoms are likely to return if treatment is stopped. Alpha-blockers will usually produce a moderate reduction in symptoms and common side effects include dizziness, headaches, a stuffy nose and stomach and intestinal problems. These problems appear in about 12% to 15% of patients.

Terms often used when talking about prostate cancer:

ANDROGEN DEPRIVATION SYNDROME (ADS): a constellation of findings associated with low levels of androgen associated with ADT.

DNA (DEOXYRIBONUCLEIC ACID): the basic biologically active chemical that defines the physical development and growth of nearly all living organisms; a complex protein that is the carrier of genetic information.

NONINVASIVE: not requiring any incision or the insertion of an instrument or substance into the body.

SEXTANT: having six parts; thus, a sextant biopsy is a biopsy that takes six samples.

Another frequently prescribed group of drugs are 5-alpha reductase inhibitors. This particular group of drugs acts to lower the level of the main male hormone found in the prostate gland and thus marginally reduces the size of the enlarged prostate. It is however a very slow acting drug and patients will normally need to take the drug for 6 to 12 months before any effects are evident.

5-alpha reductase inhibitors usually produce less of a reduction in symptoms than alpha blockers but can be particular useful in cases where the prostate is considerably enlarged and patients are at risk of developing acute retention – an inability to urinate. Common side effects resulting from the reduction of the male hormone include erection problems, a decrease in sexual desire and a reduction in the amount of semen produced. These problems are seen in about 5% to 8% of patients.

In cases where the prostate is particularly enlarged and patients are finding that they are especially troubled by their symptoms, the doctor may recommend a combination of both alpha-blockers and 5-alpha reductase inhibitors.

In addition to prescription drugs patients may also wish to consider the use of herbal remedies. A number of such over-the-counter remedies are available but, at present, their effectiveness and safety have not been proved and none are approved for use by the Food and Drug Administration (FDA). In addition, the use of some of the herbal remedies available can lead to distortions in the results of diagnostic tests and also interfere with the actions of prescription drugs. As a result, you should consult your doctor before using any form of herbal remedy.

Further information on bph:

New Thermobalancing Therapy for BPH and Chronic Prostatitis Is Free from ... - San Francisco Chronicle (press release)


New Thermobalancing Therapy for BPH and Chronic Prostatitis Is Free from ...
San Francisco Chronicle (press release)
The consideration of an impact of a prostate treatment on a man's sexual life is essential, whether treating a young male with chronic prostatitis or a mature man with benign prostatic hyperplasia (BPH). According to the Mayo Clinic, "Sexual health is ...

and more »

Getting Older Doesn't Mean Turning to BPH Drugs Without Trying New ... - Virtual-Strategy Magazine


Getting Older Doesn't Mean Turning to BPH Drugs Without Trying New ...
Virtual-Strategy Magazine
Potentially harmful BPH drugs, which are usually prescribed for life, can now be replaced with the new Thermobalancing Therapy which provides exceptional prostate treatment free from any side effects, Fine Treatment reveals. Medications can provide a ...

and more »

Urologix Announces Three Events at the 107th Annual Meeting of the American ... - MarketWatch (press release)


Urologix Announces Three Events at the 107th Annual Meeting of the American ...
MarketWatch (press release)
May 14, 2012 (GlobeNewswire via COMTEX) -- -- Sponsor of Expert Panel Lecture on In-Office BPH Therapies, Moderated by Dr. Claus Roehrborn -- Presentation of Cooled ThermoTherapy(TM) (CTT) Clinical Outcomes for Improving Nocturia by Dr. Lori Lerner ...

and more »

Nymox NX-1207 Symposium at American Urological Association Annual Meeting May ... - MarketWatch (press release)


Nymox NX-1207 Symposium at American Urological Association Annual Meeting May ...
MarketWatch (press release)
HASBROUCK HEIGHTS, NJ, May 16, 2012 (GlobeNewswire via COMTEX) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce a symposium and panel discussion on NX-1207, the Company's Phase 3 drug for benign prostatic hyperplasia (BPH), ...
NYMOX PHARMACEUTICAL CORPORATION : Nymox NX-1207 Symposium at American ...4-traders

all 4 news articles »